New innovations: Therapeutic opportunities for intellectual disabilities
Year: 2013
Type: review
Abstract: Intellectual disability is common and is associated with significant morbidity. Until the latter half of the 20th century, there were no efficacious treatments. Following initial breakthroughs associated with newborn screening and metabolic corrections, little progress was made until recently. With improved understanding of genetic and cellular mechanisms, novel treatment options are beginning to appear for a number of specific conditions. Fragile X and tuberous sclerosis offer paradigms for the development of targeted therapeutics, but advances in understanding of other disorders such as Down syndrome and Rett syndrome, for example, are also resulting in promising treatment directions. In addition, better understanding of the underlying neurobiology is leading to novel developments in enzyme replacement for storage disorders and adjunctive therapies for metabolic disorders, as well as potentially more generalizable approaches that target dysfunctional cell regulation via RNA and chromatin. Physiologic therapies, including deep brain stimulation and transcranial magnetic stimulation, offer yet another direction to enhance cognitive functioning. Current options and evolving opportunities for the intellectually disabled are reviewed and exemplified.
Source: Annals of Neurology
DOI: 10.1002/ana.24002
Authors: Jonathan D. Picker, Christopher A. Walsh
Language: English
Subfield: Genetics
Domain: Life Sciences
Keywords: intellectual disability, targeted therapeutics, fragile X syndrome, tuberous sclerosis complex, Down syndrome, Rett syndrome, enzyme replacement therapy, storage disorders, metabolic disorders, RNA-targeted therapeutics, chromatin regulation, deep brain stimulation, transcranial magnetic stimulation, cognitive enhancement, newborn screening, metabolic correction
Open Access status: green
Awards: Autism genetics: homozygosity mapping and functional validation, Human Epilepsy Genetics - Neuronal Migration Disorders, Human autism genetics and activity dependent gene activation, Somatic mutations in epilepsy: whole genome sequence analysis of single neurons, Cell Identity Determination in Human Brain: Somatic Mutation and Cell Lineage
OpenAlex ID: W2161494048
